Targeting MEK in vemurafenib-resistant hairy cell leukemia

Por Caeser, Rebecca, Collord, Grace, Yao, Wen-Qing, Chen, Zi, Vassiliou, George S., Beer, Philip A., Du, Ming-Qing, Scott, Mike A., Follows, George A., Hodson, Daniel J.
Publicado no Leukemia (2018)

Erk negative feedback control enables pre-B cell transformation and represents a therapeutic target in acute lymphoblastic leukemia

Por Shojaee, Seyedmehdi, Caeser, Rebecca, Buchner, Maike, Park, Eugen, Swaminathan, Srividya, Hurtz, Christian, Geng, Huimin, Chan, Lai N, Klemm, Lars, Hofmann, Wolf-Karsten, Qiu, Yi Hua, Zhang, Nianxiang, Coombes, Kevin R., Paietta, Elisabeth, Molkentin, Jeffery, Koeffler, H Phillip, Willman, Cheryl L, Hunger, Stephen P., Melnick, Ari, Kornblau, Steven M., Müschen, Markus
Publicado no Cancer Cell (2015)

Genetic modification of primary human B cells to model high-grade lymphoma

Por Caeser, Rebecca, Di Re, Miriam, Krupka, Joanna A., Gao, Jie, Lara-Chica, Maribel, Dias, João M. L., Cooke, Susanna L., Fenner, Rachel, Usheva, Zelvera, Runge, Hendrik F. P., Beer, Philip A., Eldaly, Hesham, Pak, Hyo-Kyung, Park, Chan-Sik, Vassiliou, George S., Huntly, Brian J. P., Mupo, Annalisa, Bashford-Rogers, Rachael J. M., Hodson, Daniel J.
Publicado no Nat Commun (2019)